louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT06914349: Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure
Official title: Antecolic Versus Retrocolic Gastrojejunostomy Following Pancreaticoduodenectomy: a Prospective Randomised Study
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Pancreatic Cancer Resectable
Pancreas Neoplasms
Keywords: Gastrojejunostomy
Whipple&#39;s
Antecolic
Retrocolic
Lead sponsor: University of Thessaly
Sponsor class: OTHER
First posted: 2025-04-06
Enrollment: 76
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Aim: This randomized clinical study aims to compare occurrence of DGE in patients undergoing either antecolic or retrocolic gastrojejunostomy following pancreaticoduodenectomy.

Methods: Participants of this study will be patients undergoing pylorus preserving pancreaticoduodenectomy at the Surgical Department of the University Hospital of Larissa. Patients will be randomized to undergo either an antecolic or a retrocolic gastrojejunostomy and the occurrence of DGE will then be compared between the two groups. Individuals younger than 18 or older than 75 years old, as well as patients who do not consent to participate in this trial, will be excluded.

Expected results: Based on available literature, antecolic gastrojejunostomy may be related with a lower incidence of DGE, without a statistically significant difference between the two methods. We aim to show if one of the two methods of gastrointestinal reconstruction (antecolic versus retrocolic) affects DGE.


Eligibility criteria: Inclusion Criteria:

* Age over 18 years old
* Elective pancreaticoduodenectomy
* Signed consent form

Exclusion Criteria:

* Age under 18 years old
* Patients who are participants in other trials that may affect the results of this study
* Patients who do not consent to participate in the study

Primary outcomes:
measure: Delayed Gastric Emptying
timeFrame: 3 years
Secondary outcomes:
Other outcomes:
Locations:
city: Larissa
country: Greece
facility: University of Thessaly
Study officials:
affiliation: University of Thessaly
name: Dimitrios Symeonidis
role: STUDY_CHAIR
References:
Clinical trial NCT01282749: Effectiveness of SisterTalk Hartford for Weight Loss Among African-American Women
Official title: The Hospitals-Churches Partnership for Health Project: SisterTalk Hartford
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Overweight
Obesity
Keywords: Overweight
Obesity
African American
Women
Translational
Faith based
Community based participatory research
Lead sponsor: UConn Health
Sponsor class: OTHER
Collaborators: name: St. Francis Hospital & Medical Center, Hartford CT
name: Brown University
First posted: 2011-01-25
Enrollment: 322
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Brief summary: The purpose of the SisterTalk Hartford study was to assess whether a theoretically- and scientifically-based, culturally acceptable weight loss program could be effectively translated into a faith-based program and subsequently delivered in the church to help African-American women lose weight.


Eligibility criteria: Inclusion Criteria:

* BMI of at least 25.0
* self-identifies as Black or African-American
* able to do mild physical activity such as walking or chair exercises

Exclusion Criteria:

* has insulin dependent diabetes
* is pregnant, nursing, or had a baby in the past 4 months
* has ever been treated for an eating disorder (e.g. anorexia nervosa, bulimia)
* had a heart attack in the past 2 years requiring hospitalization
* has ever had a stroke
* has congestive heart failure
* has uncontrolled hypertension
* currently participating in another study
* is on a doctor-prescribed diet that cannot be changed (e.g. very low protein diet for a person in liver failure)

Primary outcomes:
measure: weight loss
timeFrame: assessed 4 times over 2 years, in roughly 6 mo intervals
Secondary outcomes:
Other outcomes:
Locations:
city: Farmington
country: United States
facility: University of Connecticut Health Center
state: Connecticut
Study officials:
affiliation: UConn Health
name: Judith Fifield, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT00940849: Gastric Emptying and Gallbladder Motility Study
Official title: Gastric Emptying of Plant Sterol-containing Mini Drinks in Different Meal Intake Scenarios and Their Effect on Gallbladder Emptying
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Gastric Emptying
Lead sponsor: Maastricht University Medical Center
Sponsor class: OTHER
Collaborators: name: Unilever R&D
First posted: 2009-07-16
Enrollment: 18
Sex: MALE
Minimum age (years): 18
Maximum age (years): 55
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: BASIC_SCIENCE

Brief summary: Background of the study:

Plant sterols can play an important role in lowering plasma cholesterol. The extent to which plant sterols can reduce plasma cholesterol levels depends on the intake scenario. We suggest that the difference in these effects depends on gastric emptying and bile secretion.

Objective of the study:

The aim of this study is to gain insight in the mechanisms that may be involved in the effects of plant sterol drinks on gastric emptying and gallbladder motility. In order to test this, we compare the different effects of the consumption of a plant sterol containing drink prior to, during and after a standardized meal.


Eligibility criteria: Inclusion Criteria:

* Signed informed consent form
* Sex: male
* Age: 18-55 years
* Body Mass Index (BMI): 20-25 kg/m2

Exclusion Criteria:

* History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/psychiatric diseases, allergy, major surgery which might limit participation in or completion of the study protocol.
* Use of any medication on regular basis.
* Use of paracetamol prior to treatment (≤ 48 hour).
* Use of plant sterol/stanol enriched products or supplements 3 months prior to the study.
* Blood donations less than three months previous to study enrolment.
* Known hypersensitivity or allergy towards paracetamol.
* Hyperlipidaemia (TG \> 3 mmol/L and/or tot. chol. \> 8 mmol/L)
* Corn products prior to treatment (≤ 48 hour)
* Presence of gallbladder stones.
* Known allergy for cow milk and/or lactose intolerance

Primary outcomes:
measure: GB volume measurement by ultrasonography
timeFrame: September 2009
Secondary outcomes:
measure: GE rate measurement by 13C stable isotope breath test and plasma paracetamol concentration by clinical chemistry analysis
timeFrame: December 2009
Other outcomes:
Locations:
city: Maastricht
country: Netherlands
facility: Maastricht University Medical Center
state: Limburg
Study officials:
affiliation: Maastrich University Medical Center
name: Ad Masclee, MD PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Keszthelyi D, Knol D, Troost FJ, van Avesaat M, Foltz M, Masclee AA. Time of ingestion relative to meal intake determines gastrointestinal responses to a plant sterol-containing yoghurt drink. Eur J Nutr. 2013 Jun;52(4):1417-20. doi: 10.1007/s00394-012-0440-3. Epub 2012 Aug 23.
Clinical trial NCT06832449: Retrospective PNS Study
Official title: Retrospective Clinical Trial Investigating the Treatment of Chronic Pain With the Freedom Peripheral Nerve Stimulation System
Study type: OBSERVATIONAL
Overall status: ACTIVE_NOT_RECRUITING
Conditions: Chronic Pain
Keywords: Retrospective, chronic pain, PNS
Lead sponsor: Curonix LLC
Sponsor class: INDUSTRY
Collaborators: name: Colorado pain Care, LLC
First posted: 2025-02-18
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: 200

Brief summary: Retrospective PNS Study


Eligibility criteria: Inclusion Criteria:

A. Subjects are at least 18 years of age, B. Subjects have been diagnosed with refractory chronic pain, C. Subject has been implanted with a permanent Freedom Peripheral Nerve Stimulation System.

Exclusion Criteria:

A. Any additional active implanted devices for the treatment of chronic pain in addition to the Freedom Peripheral Nerve Stimulation System.

Primary outcomes:
measure: VRS
timeFrame: 36 months
Secondary outcomes:
measure: Health economic data
timeFrame: 12 months
Other outcomes:
Locations:
city: Denver
country: United States
facility: Colorado Pain Care
state: Colorado
Study officials:
References:
Clinical trial NCT04357249: Outcome of Capsular After Pediatric Cataract Surgery With Primary Intraocular Lens Implantation
Official title: Outcome of Capsular After Pediatric Cataract Surgery With Primary Intraocular Lens Implantation
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Pediatric Cataract
Lead sponsor: Wenzhou Medical University
Sponsor class: OTHER
First posted: 2020-04-22
Enrollment: 50
Sex: ALL
Maximum age (years): 10
Standard ages: CHILD
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Participants included eyes of children with unilateral or bilateral cataract.

Brief summary: The aim of this study is to evaluate the outcome of capsular in children with cataract, and to explore potential preoperative structural clues for postoperative glaucoma. The investigators included children with cataract planning to have cataract surgery in our institute. Exclusion criteria were: a history of ocular trauma, a history of intraocular surgery, preoperative glaucoma, steroid use before surgery, a history of maternal rubella syndrome, chronic anterior uveitis, persistent fetal vasculature, ocular anomalies associated with an increased risk of glaucoma, unable to complete examinations. The investigators recorded age at surgery, gender and relevant ocular and systemic histories. All patients underwent slit lamp biomicroscopy, slit lamp adapted anterior segment photography.All patients were examined at 1 week, 1 month, 3 months, 6 months, 1 year, 18 months, and two years after surgery. Patients were followed for two years or until the development of severe VAO requiring Nd: YAG laser capsulotomy, whichever came first. The examinations consisted of visual acuity, IOP measurement by a Tonopen tonometer (Reichert, Inc., Seefeld, Germany), fundoscopy, an assessment by high-resolution digital retroillumination imaging (detailed protocol presented below).The primary outcomes were the areas of the posterior capsular opening at different postoperative follow-up visits and during operation.A paired T test was used to compare the areas of the PCO between the postoperative visits and baseline.


Eligibility criteria: Inclusion Criteria:

Participants included eyes of children with unilateral or bilateral cataract.

Exclusion Criteria:

Patients with glaucoma, ocular trauma, corneal disorders, persistent hyperplastic primary vitreous, rubella, Lowe syndrome, capsular fibrosis, or surgical complications, as well as those whose pupils could not dilate normally postoperation or who could not complete the follow-up, were excluded.

Primary outcomes:
measure: area of PCO
timeFrame: 2015.5.1- 2020.8-1
Secondary outcomes:
Other outcomes:
Locations:
city: Wenzhou
country: China
facility: Wenzhou Medical Colledge
state: Zhejiang
Study officials:
affiliation: executive dean
name: ZHAO YUNE, MD
role: STUDY_DIRECTOR
References:
Clinical trial NCT04348006: Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients
Official title: Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients
Study type: INTERVENTIONAL
Overall status: WITHDRAWN
Phase: PHASE4
Conditions: Newly Diagnosed Multiple Myeloma
Lead sponsor: Al-Rasheed University College
Sponsor class: OTHER
Collaborators: name: Baghdad Medical City
First posted: 2020-04-15
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Bortezomib considered the standard of care for treating multiple myeloma patients, the aim was to assess the safety and efficacy of newly approved drug (Alvocade ®) in Iraq, in newly diagnosed patients.


Eligibility criteria: Inclusion Criteria:

* Newly diagnosis Multiple myeloma with CRAB (C: hypercalcemia, R: renal impairment, A: anemia, and B: bone lesions)
* Age above 18 years old

Exclusion Criteria:

* Age below 18 years
* Smoldering MM

Primary outcomes:
measure: Assessment the safety of Alvocade® therapy
timeFrame: During 6 months
measure: Assessment the effecacy of Alvocade® therapy
timeFrame: At end of 6 months
Secondary outcomes:
measure: First assessment response
timeFrame: At end of 2 months
measure: Second assessment response
timeFrame: At end of 4 months
measure: Third assessment response
timeFrame: At end of 6 months
Other outcomes:
Locations:
city: Baghdad
country: Iraq
facility: Baghdad Hematology center - Baghdad Medical City
state: Bab-Almuadham
Study officials:
affiliation: Baghdad college of medicine
name: Ali M Jawad, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad Medical City
name: Bassam F Matti, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad Medical City
name: Tareq A Saleh, PhD
role: STUDY_CHAIR
affiliation: Baghdad Medical City
name: Mahammed S Abbas, PhD
role: STUDY_DIRECTOR
affiliation: Baghdad Medical City
name: Mohammed K Al-Qayyim, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad college of medicine
name: Alaaldin S Naji, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad Medical City
name: Ammer F Majid, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad Medical City
name: Adil S Al-Oqaby, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad Medical City
name: Mazin A Shubir, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Baghdad Medical City
name: Hawraa D Jumaa, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Al-Rasheed University College
name: Hayder A Fawzi, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01835106: Efficacy of an Epidural Versus a Fascia Iliaca Compartment Catheter After Hip Surgery
Official title: A Prospective, Randomized, Double-blind, Placebo-controlled, Crossover Trial of Epidural Analgesia Versus a Surgically-placed Fascia Iliaca Compartment Catheter for Postoperative Pain After Periacetabular Osteotomy
Study type: INTERVENTIONAL
Overall status: WITHDRAWN
Phase: NA
Conditions: Postoperative Pain
Keywords: Postoperative Care
Lead sponsor: Boston Children's Hospital
Sponsor class: OTHER
First posted: 2013-04-18
Enrollment: 0
Sex: ALL
Minimum age (years): 15
Maximum age (years): 35
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The investigators are investigating two ways of treating pain after hip surgery. One way is though a thin tube (called a catheter), and it is placed into the back so that pain-numbing drugs can reach the nerves near the backbone. This is called an "epidural" catheter. Another way is to place the catheter close to the hip, where the surgery is done, so that the pain-numbing drugs can reach some of the nerves more locally. This is called a "fascia iliaca compartment" catheter.

The investigators do not know which way is best to treat pain, or has fewer side effects, or allows a patient to leave hospital faster. Usually, patients would receive only one type of catheter for pain relief. To do this comparison, the investigators would place both catheter types, so that patients help us tell which one works better.


Eligibility criteria: Inclusion Criteria:

* Weight \>40 kg
* Radiographic evidence of hip dysplasia amenable to unilateral surgical treatment by periacetabular osteotomy
* Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale \>4/20
* Age between 15 and 35 years
* Good or excellent preoperative joint congruency

Exclusion Criteria:

* Hematologic or neurologic contraindications to epidural catheter placement
* Significant renal, hepatic, or cardiac disease
* Peptic ulcer disease
* Bleeding disorders
* Severe asthma
* Hypersensitivity to non-steroidal antiinflammatory drugs
* Developmental delay
* History of substance abuse
* Chronic opioid use
* Chronic pain in non-hip locations

Primary outcomes:
measure: Number of days until all pre-defined readiness-to-discharge criteria for hip surgery are met
timeFrame: 1-5 days
Secondary outcomes:
Other outcomes:
Locations:
city: Boston
country: United States
facility: Boston Children's Hospital
state: Massachusetts
Study officials:
affiliation: Boston Children's Hospital
name: Luke Y Wang, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06625606: Continuous Versus Single-Shot Spinal Anesthesia for Orthopedic Surgery
Official title: Continuous Spinal Anesthesia for Patients Planned For Major Orthopedic Surgeries: Versus Single-Shot Spinal Anesthesia: A Case-Control Comparative Study
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Post Operative Pain
Lead sponsor: Benha University
Sponsor class: OTHER
First posted: 2024-10-03
Enrollment: 105
Sex: ALL
Minimum age (years): 60
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: A study was conducted to compare the effectiveness of continuous spinal anesthesia (CSA), single-shot spinal anesthesia (SSSA), and general anesthesia (GA) in patients over 60 years of age undergoing elective surgical repair of a fractured neck of femur. One hundred and five patients were randomly assigned to one of the three groups. The SSSA group received a single intrathecal injection of isobaric bupivacaine 0.5%, while the CSA group received multiple injections of the same anesthetic through a catheter placed in the subarachnoid space. The GA group received isoflurane anesthesia. Intraoperatively, blood pressure was monitored to assess the frequency of hypotension and the required dose of ephedrine. Additionally, the total dose of bupivacaine administered and the frequency of intraoperative fentanyl were recorded. Postoperatively, the duration of postoperative analgesia, pain scores, and need for additional pain medication were evaluated.


Eligibility criteria: Inclusion Criteria:

* Patients of American Society of Anesthesiologists (ASA) grade ≤III;
* Patients were assigned for elective surgical intervention for Fixation of Neck Femur;
* Patients were free of exclusion criteria.

Exclusion Criteria:

* Patients of American Society of Anesthesiologists (ASA) grade \>III;
* Patients who had uncontrolled hypertension and/or diabetes mellitus;
* Patients who had uncompensated cardiac, renal, or hepatic diseases;
* Patients with coagulopathy, spinal deformity, allergy, or contraindication for the used drugs;
* Patients who refused to sign the informed consent were excluded from the study.

Primary outcomes:
measure: Proportion of patients reporting at least a 50% reduction in pain (measured by Numerical Rating Scale) post orthopedic surgery.
timeFrame: 3 months
Secondary outcomes:
Other outcomes:
Locations:
city: Banhā
country: Egypt
facility: Benha University
state: El Qalyoubia
Study officials:
References:
Clinical trial NCT04494906: Interactive Stepping Exercise on Balance and Cognitive Function
Official title: Effects of Interactive Stepping Exercise on Balance and Cognitive Function in Individuals With Parkinson's Disease
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Parkinson's Disease
Keywords: Interactive stepping exercise
Square stepping exercise
Parkinson's disease
Balance ability
Cognitive function
Lead sponsor: National Yang Ming Chiao Tung University
Sponsor class: OTHER
First posted: 2020-07-31
Enrollment: 40
Sex: ALL
Minimum age (years): 50
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The objective of this study is to investigate the effects of interactive stepping exercise on balance and cognitive function in individuals with PD.


Eligibility criteria: Inclusion Criteria:

* Idiopathic PD
* Hoehn \& Yahr stage between 1 to 3
* Age between 50 to 85
* Stable pharmacologic treatment for the last 2 weeks
* Ability to walk 10 meters unassisted or with assistive devices

Exclusion Criteria:

* Other neurological disorders diagnosis than PD
* Receiving any neurological surgeries
* Any musculoskeletal disorder or cardiopulmonary disease that may influence participation in the study
* The Mini-Mental State Examination (MMSE) \< 24 scores
* Participated in other exercise intervention of study in the past 3 months
* Colorblindness or color vision deficiency

Primary outcomes:
measure: Romberg test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Sharpened Romberg test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: One-leg stance test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Timed up and go test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Mini-Balance Evaluation Systems Test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Montreal Cognitive Assessment Chinese version
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Digit span test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Stroop color and word test Chinese version
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Trail-making test Chinese version
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Spatial span test
timeFrame: Change from baseline at 8 weeks and 12 weeks
Secondary outcomes:
measure: 10-meter walk test
timeFrame: Change from baseline at 8 weeks and 12 weeks
measure: Parkinson's Disease Questionnaire 39
timeFrame: Change from baseline at 8 weeks and 12 weeks
Other outcomes:
Locations:
city: Taipei
country: Taiwan
facility: National Yang-Ming University
Study officials:
References:
Clinical trial NCT03955406: Low Flow Anesthesia Without Initial High Flow Phase
Official title: Comparison of Low Flow Anesthesia With and Without Initial High Flow Phase
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Low Flow Anesthesia
Volatile Anesthetic Consumption
Lead sponsor: Kahramanmaras Sutcu Imam University
Sponsor class: OTHER
First posted: 2019-05-20
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: The aim of the study is to compare the effectiveness of conventional low flow anesthesia (LFA) with initial high fresh gas flow ( 4L/min) for 10 minutes and LFA with fixed fresh gas flow rate (1L/min).


Eligibility criteria: Inclusion Criteria:

* ASA 1-3
* scheduled for surgery under general anesthesia with endotracheal intubation

Exclusion Criteria:

* hemodynamic instability
* emergency cases
* expected anesthesia duration \< 60 min
* patient refusal

Primary outcomes:
measure: The time required to reach 0.7 MAC
timeFrame: perioperative
measure: number of adjustments made to the vaporizer settings
timeFrame: perioperative
Secondary outcomes:
measure: anesthetic agent consumption
timeFrame: perioperative
Other outcomes:
Locations:
city: Kahramanmaras
country: Turkey
facility: Kahramanmaras Sutcu Imam University
state: In The USA Or Canada, Please Select...
Study officials:
References: